Specialty Pharmaceuticals Company Investment Opportunity in Nieuwegein, Netherlands

The facility will have a growing/extraction/distillation/R&D laboratory in order to follow the entire stage of production from mother plant till crystallized form of cannabinoid. With further R&D on lesser known cannabinoids for finding additional uses and health benefits.

Later on we will be focusing on the distribution channels in each country of presence in order to be prepared to scale to the B2C market with generic medicine and potentially edibles, but that will be decided by the market needs.

We have received installation licence for such end products and as the project progresses we will be adding new products to the list:

-Dried hemp flower > 0.2% THC in the form of teabag (tea bag) for oral consumption;

-Hemp oil in drops for oral consumption > 0.2% THC;

-Hemp oil for sublingual oral consumption (spray) > 0.2% THC;

-Soft cannabis capsules for oral consumption > 0.2% THC;

-Capsules with dried hemp blossom > 0.2% THC in powder form for oral consumption.

At the moment we have:

License and permits;

Architectural and engineering plans;

Purchase offers from equipment suppliers;

All described production processes and laboratories;

Long-term land lease for 30+ years with an option to purchase it;

The entire legal structure of the holding;

Verification of processes and architectural solutions under EU GACP & EU GMP standards.

Currently applying for the State Subsidy that cover up to 60% of Capex costs of the project + with an option for fixed corporate Tax for 12 years.

Overall the production facility is projected to grow 6.5+ tons of dried biomaterial on a single tier growing table with ability of scaling.

The EU GMP Laboratory is projected to produce 2.5+ tons of fine oil with an option of scaling by putting second processing line.

Additionally the project is built in mind with an option for a secondary stage expansion through the built of additional production site on the neighboring land.

- Medical flower.

- Pharma grade extracted oils.

- Pharma grade separate cannabinoids.

- Waxes.

- Terpenes.

- Combined API.

License and permits;

Architectural and engineering plans;

Purchase offers from equipment suppliers;

All described production processes and laboratories;

Long-term land lease for 30+ years with an option to purchase it;

The entire legal structure of the holding;

Three corporate bank accounts in Belgium, Portugal, Greece;

Verification of processes and architectural solutions under EU GACP & EU GMP standards;

Compiling file for the Government Subsidy Program (could cover up to 60% of the Capex costs).

The facility will have a combined area of 6,500 square meters.

The production facility is single floor with 4.950 square meters of total area with 2150 sq meters of flowering zone.

The office is 2 floor building with usable roof terrace.

The R&D Lab is 193 square meters.

Long-term land lease for 30+ years with an option to purchase it.